KCT0004099已完成未知
The use of inhaled N-acetylcysteine for laryngopharyngeal reflux disease: A randomized controlled trial
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •1. symptoms of LPRD : globus (a sensation of a lump in the throat), throat clearing, hoarseness, postnasal drip (PND) sense and cough
- •2. reflux symptom index (RSI) greater than 13
- •3. reflux finding scores (RFS) greater than 7
排除标准
- •patients with acute or chronic sinusitis or with symptoms of upper respiratory infection at initial visit, patients with lower respiratory disease such as asthma, chronic obstructive pulmonary disease, pneumonia, or lung cancer, patients with organic lesions in the pharynx, larynx, or oral cavity such as malignancy, significant hypertrophy of palatine or lingual tonsil, or huge vallecular cyst, patients who had psychiatric history such as depression or insomnia or those taking psychiatric medication, patients older than 70 years, younger than 20 years, or pregnant, patients currently taking PPI
研究者
相似试验
已完成
不适用
Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosisJPRN-UMIN000016706Saitama Red Cross Hospital25
已完成
不适用
The effect of N-acetylcystein in outcome and adverse effects of intubation in neonatesRespiratoty Distress Syndrome of neonates.Respiratory distress syndrome of newbornIRCT138810012420N2Vice chancellor for research, Iran University of Medical Sciences and Health Services65
Unknown
4 期
The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal SymptomsChronic Sinonasal SymptomsNCT00866866University of Calgary60
进行中（未招募）
不适用
The effect of inhaled N-Acetylcysteine compared to normal saline on sputum rheology and lung functioCystic FibrosisEUCTR2008-008317-20-BEniversity Hospital Ghent
进行中（未招募）
1 期
Injection of N-acetylcysteine through the eardrum to reduce hearing loss related to Cisplatin chemotherapy.OtotoxicityMedDRA version: 20.0Level: PTClassification code 10033109Term: OtotoxicitySystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2019-004463-44-BECHU Saint Pierre86